Parascaris equorum, commonly known as equine ascarids or roundworms, represents one of the most significant parasitic threats to foals and young horses worldwide. These large nematodes, which can reach lengths of up to 50 centimeters, are among the largest parasites affecting horses and can cause serious disease including respiratory distress, intestinal obstruction, and impaired growth. The parasite has a complex life cycle involving migration through the liver and lungs before maturing in the small intestine, causing damage to multiple organ systems during its development.
Ascarid infections occur universally in horse populations, with foals being particularly vulnerable due to their naive immune systems and ground-level feeding behaviors that increase egg ingestion. Studies consistently demonstrate that nearly 100 percent of foals become infected during their first year of life when raised on premises with resident horse populations. The prevalence and severity of infection typically peak between two and six months of age, with most horses developing effective immunity by age two that limits adult worm establishment in subsequent exposures.
The impact of ascarid infection on young horse health and development can be substantial. Heavy worm burdens interfere with nutrient absorption, leading to poor growth rates, rough hair coats, and pot-bellied appearances characteristic of parasitized foals. Larval migration through the lungs causes coughing and respiratory disease, while large numbers of adult worms in the small intestine can lead to potentially fatal intestinal impaction or rupture. Performance potential may be compromised in horses experiencing significant parasitism during critical developmental periods.
Despite the serious nature of ascarid infection, effective treatment options exist, and strategic deworming programs can successfully protect young horses during their vulnerable period. The increasing recognition of anthelmintic resistance in Parascaris populations has transformed management approaches, emphasizing targeted treatment based on fecal egg counts rather than routine interval dosing. Early detection through regular monitoring allows intervention before clinical disease develops, protecting both individual horse health and preserving the efficacy of available treatments for future use.
